KAITLYN HILL: Open Payments
NPI 1982204640 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 70 payments from 19 companies in 2025. Trend: 2023 $460 · 2024 $2,648 · 2025 $2,106
Food & beverage: $2,022Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $490 |
| Janssen Biotech, Inc. | 8 | $380 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $198 |
| Ardelyx, Inc. | 4 | $148 |
| Intercept Pharmaceuticals, Inc. | 1 | $125 |
| PFIZER INC. | 6 | $124 |
| GENZYME CORPORATION | 2 | $110 |
| Lilly USA, LLC | 4 | $96 |
| Regeneron Pharmaceuticals, Inc. | 1 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, ENTYVIO, IBSRELA, LINZESS, OCALIVA.
Industry payments across MI — which companies pay providers there.
